Action Radiopharm Theranostics - RADX

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

4,19

Prix Achat

3,51

Prix Vente

5,14

Volume échangé

244

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

4,46

Ouverture

Dernière Transaction

3.5

Dernière heure de transaction

14:35:50

Volume moyen (3 m)

Volume financier

VWAP

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study is designed to assess the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form F-1 - Registration statement for certain foreign private issuers

Radiopharm Achieves Nasdaq Listing of American Depositary Shares

Trading under ticker symbol RADXComplements existing US shareholders (currently holding 21% of Radiopharm)No associated capital raisingModest admin & financial compliance overheads SYDNEY...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

RADX - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics share price?

The current share price of Radiopharm Theranostics is US$ 4,19

What is the 1 year trading range for Radiopharm Theranostics share price?

Radiopharm Theranostics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MYSZMy Size Inc	US$ 5,52 (308,89%)	39,11M
LYTLytus Technologies Holdings PTV Ltd	US$ 3,30 (228,36%)	17,83M
HSDTHelius Medical Technologies Inc	US$ 0,9987 (108,06%)	47,77M
TAOPTaoping Inc BVI	US$ 0,58 (82,97%)	46,34M
NVNINVNI Group Ltd	US$ 4,55 (70,41%)	8,4M
CYNCYNGN Inc	US$ 0,73 (-54,66%)	568,61k
MTEMMolecular Templates Inc	US$ 0,1819 (-48,03%)	935,23k
HYZNHyzon Motors Inc	US$ 1,03 (-37,95%)	75,71k
PRFXPainReform Ltd	US$ 7,10 (-36,38%)	428,31k
GALTGalectin Therapeutics Inc	US$ 1,36 (-32,00%)	1,17M
HSDTHelius Medical Technologies Inc	US$ 0,9938 (107,04%)	47,84M
TAOPTaoping Inc BVI	US$ 0,5799 (82,93%)	46,36M
APTOAptose Biosciences Inc	US$ 0,287 (68,63%)	42,15M
MYSZMy Size Inc	US$ 5,52 (308,89%)	39,11M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,549 (-3,68%)	24,55M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Radiopharm Theranostics Ltd (RADX)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

RADX Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form F-1 - Registration statement for certain foreign private issuers

Radiopharm Achieves Nasdaq Listing of American Depositary Shares

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form F-1 - Registration statement for certain foreign private issuers

RADX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Radiopharm Theranostics Ltd (RADX) Cours

Radiopharm Theranostics Ltd (RADX)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

RADX Dernières nouvelles

RADX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR